Drug combination studies of EZH2 inhibition combined with ATM, PI3-Kinase and CDK inhibitors in BRCA1-deficient breast tumors
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
Köln, Universität zu Köln, Dissertation, 2023
- Keyword
-
Krebs
Brustkrebs
Molekularbiologie
- Event
-
Veröffentlichung
- (where)
-
Köln
- (who)
-
Universitäts- und Stadtbibliothek Köln
- (when)
-
2023
- Creator
-
Bartke, Leandra
- Contributor
-
Reinhardt, Christian
Niessen, Carien
- URN
-
urn:nbn:de:hbz:38-713814
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:49 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Bartke, Leandra
- Reinhardt, Christian
- Niessen, Carien
- Universitäts- und Stadtbibliothek Köln
Time of origin
- 2023
Other Objects (12)
Combined inhibition of EZH2 and ATM is synthetic lethal in BRCA1-deficient breast cancer
Combination of EZH2 and ATM inhibition in BAP1-deficient mesothelioma
BRCA1 deficient mammary tumors are dependent on EZH2 expression and sensitive to polycomp repressive complex 2-inhibitor 3-deazaneplanocin A
CDK
BRCA1-deficient mammary tumor cells are dependent on EZH2 expression and sensitive to Polycomb Repressive Complex 2-inhibitor 3-deazaneplanocin A
Convent Deutscher Kooperationsverbände (CDK): CDK .- Bundeszuschüsse
Funktionelle und mechanistische Charakterisierung von EZH2 in Atm-defizienten Subtypen des Pankreaskarzinoms
The biology and molecular vulnerabilities of ATM-deficient cancers
CDK-Conventsprotokolle
CDA / CDK
CDK news : the newsletter of the CDK projekt ; CDK news is a publication of the Chemistry Development Kit (CDK) project
Mechanisms of increased risk of tumorigenesis in Atm and Brca1 double heterozygosity
Combined inhibition of EZH2 and ATM is synthetic lethal in BRCA1-deficient breast cancer
Combination of EZH2 and ATM inhibition in BAP1-deficient mesothelioma
BRCA1 deficient mammary tumors are dependent on EZH2 expression and sensitive to polycomp repressive complex 2-inhibitor 3-deazaneplanocin A
CDK
BRCA1-deficient mammary tumor cells are dependent on EZH2 expression and sensitive to Polycomb Repressive Complex 2-inhibitor 3-deazaneplanocin A
Convent Deutscher Kooperationsverbände (CDK): CDK .- Bundeszuschüsse
Funktionelle und mechanistische Charakterisierung von EZH2 in Atm-defizienten Subtypen des Pankreaskarzinoms
The biology and molecular vulnerabilities of ATM-deficient cancers
CDK-Conventsprotokolle
CDA / CDK
CDK news : the newsletter of the CDK projekt ; CDK news is a publication of the Chemistry Development Kit (CDK) project
Mechanisms of increased risk of tumorigenesis in Atm and Brca1 double heterozygosity
Combined inhibition of EZH2 and ATM is synthetic lethal in BRCA1-deficient breast cancer
Combination of EZH2 and ATM inhibition in BAP1-deficient mesothelioma
BRCA1 deficient mammary tumors are dependent on EZH2 expression and sensitive to polycomp repressive complex 2-inhibitor 3-deazaneplanocin A
CDK
BRCA1-deficient mammary tumor cells are dependent on EZH2 expression and sensitive to Polycomb Repressive Complex 2-inhibitor 3-deazaneplanocin A
Convent Deutscher Kooperationsverbände (CDK): CDK .- Bundeszuschüsse
Funktionelle und mechanistische Charakterisierung von EZH2 in Atm-defizienten Subtypen des Pankreaskarzinoms
The biology and molecular vulnerabilities of ATM-deficient cancers
CDK-Conventsprotokolle
CDA / CDK
CDK news : the newsletter of the CDK projekt ; CDK news is a publication of the Chemistry Development Kit (CDK) project